glp-1/gip agonists Schematic illustration of monoagonists, dual and triple Frontiers | Mechanisms of action
Description
Published 2021-5-11 Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD), including atherosclerosis, hypertension and heart failure
Surg Obes Relat Dis 14(9):13681372 Brown AM, Yang J, Zhang X, Docimo S, Pryo AD, Spaniolas K (2022) Bariatric surgery lowers the risk of major cardiovascular events
Xiong H, Zheng C, Wang J, et al
So far, the co-agonist drugs which have reached phase 2 trials have demonstrated an improved glycaemic profile with chronic administration
It lists savings up to $563/month, reducing the cost per month to $550
